Streetbeat News

Revenues

PCOR

Procore Technologies shares are trading lower after the company reported Q2 financial results and issued Q3 revenue guidance below estimates.

Portfolio Pulse from Benzinga Newsdesk

August 02, 2024 | 11:38 am

PAA

Plains All American Pipeline (PAA) has raised its FY24 Adjusted EBITDA outlook by $75 million to a new range of $2.725 billion to $2.775 billion. The company also reiterated its full-year 2024 Adjusted Free Cash Flow guidance of $1.55 billion.

Portfolio Pulse from Benzinga Newsdesk

August 02, 2024 | 11:37 am

TWST

Twist Bioscience has updated its Q4 2024 revenue guidance to $82M-$83M, surpassing both its prior guidance of $77M-$80M and the consensus estimate of $79.602M. The company also expects a gross margin of approximately 44% and an adjusted EBITDA loss of $20 million.

Portfolio Pulse from Benzinga Newsdesk

August 02, 2024 | 11:37 am

CME

CME Group reported a new July average daily volume (ADV) record of 24.8 million contracts, a 24% increase from July 2023. The company's interest rate, equity index, metals, agricultural, and options products also reached July ADV records, with the U.S. Treasury complex hitting a new July volume record of 6.6 million contracts.

Portfolio Pulse from Benzinga Newsdesk

August 02, 2024 | 11:36 am

PAGP

Plains GP Holdings (NASDAQ:PAGP) reported Q2 2024 earnings per share (EPS) of $0.20, missing the analyst consensus estimate of $0.31 by 35.48%. However, the company reported sales of $12.930 billion, beating the estimate of $12.409 billion by 4.20%. Compared to the same period last year, EPS decreased by 20%, while sales increased by 11.47%.

Portfolio Pulse from Benzinga Newsdesk

August 02, 2024 | 11:35 am

TWST

Twist Bioscience has updated its financial guidance for fiscal year 2024, expecting total revenue of $310M-$311M, up from prior guidance of $300M-$304M and above the consensus of $303.906M. The company anticipates growth in SynBio and NGS revenues, while Biopharma revenue is expected to decline. Gross margin is projected at the high end of previous guidance, and loss from operations is slightly improved. Capital expenditure is reduced, and ending cash is expected to be higher than previously forecasted.

Portfolio Pulse from Benzinga Newsdesk

August 02, 2024 | 11:35 am

CBOE

Cboe Global Markets has updated its fiscal year 2024 guidance, expecting net revenue growth of 6%-8%, up from the previous 5%-7%. The company reaffirmed its adjusted operating expenses, depreciation and amortization expenses, minority investment contributions, effective tax rate, and capital expenditures.

Portfolio Pulse from Benzinga Newsdesk

August 02, 2024 | 11:34 am

PAA

Plains All American (NASDAQ:PAA) reported Q2 2024 earnings per share of $0.31, meeting analyst expectations, and sales of $12.930 billion, surpassing the $12.836 billion estimate. This represents a 24% increase in EPS and an 11.45% increase in sales compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 02, 2024 | 11:34 am

PPL

PPL Corporation (NYSE:PPL) reported strong Q2 2024 results, with adjusted EPS of $0.38 beating estimates by 15.15% and sales of $1.880 billion surpassing expectations by 14.53%. Both metrics showed significant year-over-year growth.

Portfolio Pulse from Benzinga Newsdesk

August 02, 2024 | 11:34 am

TDS

Telephone and Data Systems (TDS) has reaffirmed its 2024 guidance for UScellular service revenues at $2.95 billion to $3.05 billion. However, it has revised its TDS Telecom total operating revenues to $1.05 billion to $1.08 billion, down from the previous range of $1.07 billion to $1.10 billion.

Portfolio Pulse from Benzinga Newsdesk

August 02, 2024 | 11:34 am